Preclinical results of Doer Biologics' DR319 project will be presented at the upcoming American Association for Cancer Research (AACR) Annual Meeting 2026. The conference will take place in San Diego, USA, from April 17 to 22, 2026.
For details on the presentation time, session, and abstract information, please refer to the link：https://www.abstractsonline.com/pp8/#!/21436/presentation/4376